Combination immunotherapy: the new standard of care for metastatic kidney cancer
The following video interviews discuss combinations of immunotherapy drugs and [...]
The benefits of immunotherapy combinations
This article, published in Nature just before Christmas, gives a [...]
Sequencing of treatments for advanced kidney cancer remains uncertain
There are now a number of licensed drug options available [...]
Scientists discover the mechanism for resistance to immunotherapy treatment
Scientists from the Dana-Farber Cancer Institute in Boston, USA, have [...]
Pembrolizumab investigated as adjuvant therapy for renal cell carcinoma
Immunotherapy has been a major breakthrough in the treatment of [...]
Management of bone metastases in renal cell carcinoma
The following video from Practise Update is an interview with [...]
Adjuvant therapy for renal cell carcinoma
The following article is a good review of the data [...]
Positive interim results for atezolizumab plus bevacizumab combination in advanced RCC
Interim results from the phase III IMmotion151 study to assess [...]
The evolving management of advanced renal cell carcinoma
This article, published in UroToday this week, is a nice summary [...]
Neoadjuvant and adjuvant therapy for renal cell carcinoma: critique, current trials and future directions
The following articles discuss the use of neoadjuvant therapy (drug [...]
